Vitamin D Inhibition of the Prostaglandin Pathway as Therapy for Prostate Cancer

Authors

  • David Feldman MD,,

    Corresponding author
    1. Department of Medicine/Endocrinology, Stanford University School of Medicine, Stanford, California, USA
      Department of Medicine/Endocrinology, Stanford University School of Medicine, 300 Pasteur Drive, Room S-025, Stanford, CA 94305–5103, USA; Phone: 650–725–2910; Fax: 650–725–7085; E-mail: feldman@cmgm.stanford.edu
    Search for more papers by this author
  • Aruna Krishnan PhD,,

    1. Department of Medicine/Endocrinology, Stanford University School of Medicine, Stanford, California, USA
    Search for more papers by this author
  • Jacqueline Moreno PhD,,

    1. Department of Medicine/Endocrinology, Stanford University School of Medicine, Stanford, California, USA
    Search for more papers by this author
  • Srilatha Swami PhD,,

    1. Department of Medicine/Endocrinology, Stanford University School of Medicine, Stanford, California, USA
    Search for more papers by this author
  • Donna M. Peehl PhD,,

    1. Department of Urology, Stanford University School of Medicine
    Search for more papers by this author
  • Sandy Srinivas MD

    1. Department of Medicine/Oncology, Stanford University School of Medicine
    Search for more papers by this author

Department of Medicine/Endocrinology, Stanford University School of Medicine, 300 Pasteur Drive, Room S-025, Stanford, CA 94305–5103, USA; Phone: 650–725–2910; Fax: 650–725–7085; E-mail: feldman@cmgm.stanford.edu

No abstract is available for this article.

Ancillary